Thu, Mar 5, 2015, 7:15 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

StemCells Inc. Message Board

  • rookie_at_this_2013 rookie_at_this_2013 Nov 30, 2013 10:28 AM Flag

    Barrons article says Stem has enough cash

    to get through 2015. Researching this company, theres a lot more going on.

    Hot Research | TUESDAY, OCTOBER 22, 2013
    StemCells Seen Funded Through 2015
    Article
    Comments
    Why Subscribe?

    StemCells (STEM: NYSE) By Maxim Group ($1.47, Oct. 21, 2013) StemCells announced Oct. 8 that the company closed an underwritten public offering of common stock and warrants. StemCells (ticker: STEM) sold a total of 12,845,500 units, which includes the underwriter's ...

    You need to subscribe to Barrons to get the rest. The Patent Infringement case against Cur is coming to an end in early 2014.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • If that is the case, why is STEM management pursuing approval to issue more shares?

    • STEM: Another loss for the last quarter - approximately $7.1 Million loss

      Again: ----- STEM after 21 Years has NEVER Shown a Profit

      Total investment contribution: Approximately $300 Million

      Continuous dilution for 21 years !!!!!!!

      Reverse split was orchestrated by insiders.

      The STEM insiders DUMPED their shares before the reverse split.

      STEM insiders sold before the1 for 10 reverse split

      After 1 for 10 reverse split – STEM insiders granted themselves boatloads of FREE shares

      STEM stock has lost approximately 98% of its value from its al time high.....LOST 98% OF its VALUE!

      Bottom line: Where is the $300 Million?

      Shareholders need to stop the potential STEM bankruptcy that is on the horizon Do the math. How much more does STEM get diluted as the stock price falls?

      1. There needs to be more major shareholders to implement positive changes.
      2. A new STEM Board of Directors needs to be voted in
      3. A new STEM CEO to be voted in
      4. Cost controls implemented.
      5. Salary reductions of 40% or more for STEM employees
      6. The FREE share grants STEM employees received need to be taken back and receded.

      Or merge STEM with CUR: Let the highly qualified management team and Board of Directors from CUR run the combined company going forward.

    • Since that aticle STEM has lost approximately 20% of its value.

      If STEM does not attempt to initiate a merger with Neuralstem Inc. then here are the likely alternatives:

      1. STEM declining stock price
      2. More expected insider selling of STEM
      3. Potential for another REVERSE SPLIT of the STEM stock
      4. Squandered cash reserves
      5. Insiders grant themselves more free shares
      6. MASSIVE stock dilution of the STEM stock
      7. Investors flee
      8. FDA trials could be precarious
      9. Patients may not enroll in FDA trials
      10. Continued squandered cash reserves lessens the leverage for a successful merger any other company
      11. Continued squandered cash reserves lessens the chance of a buyout of STEM

      There is only ONE preferred solution: STEM Board of Directors needs to initiate a merger with Neuralstem Inc. while STEM still has cash reserves of approximately $37 Million and also has leverage with the STEM intellectual portfolio of patents. If a merger is not initiated....... you can see the potential "Step 12".....STEM BANKRUPTCY!

 
STEM
1.29+0.05(+4.03%)Mar 5 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Geron Corporation
NASDAQThu, Mar 5, 2015 4:00 PM EST
Orexigen Therapeutics, Inc.
NASDAQThu, Mar 5, 2015 4:00 PM EST
Orbital ATK, Inc.
NYSEThu, Mar 5, 2015 4:02 PM EST